Genmab A/S Files 6-K, Incorporates by Reference
Ticker: GNMSF · Form: 6-K · Filed: Nov 18, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Nov 18, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, regulatory-update, incorporation-by-reference
Related Tickers: GMAB
TL;DR
Genmab 6-K filed Nov 18, 2025, incorporates announcements into existing S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on November 18, 2025, to report company announcements. This filing is incorporated by reference into several of Genmab's existing S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
Why It Matters
This filing ensures that important company updates are officially part of Genmab's public record and integrated into its existing SEC filings, providing transparency for investors.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous announcements and does not introduce new financial or operational risks.
Key Players & Entities
- Genmab A/S (company) — Registrant
- November 18, 2025 (date) — Filing Date
- 333-232693 (registration_statement_file_number) — Incorporated S-8 Filing
- 333-253519 (registration_statement_file_number) — Incorporated S-8 Filing
- 333-262970 (registration_statement_file_number) — Incorporated S-8 Filing
- 333-277273 (registration_statement_file_number) — Incorporated S-8 Filing
- 333-284876 (registration_statement_file_number) — Incorporated S-8 Filing
FAQ
What is the purpose of this Form 6-K filing by Genmab A/S?
The purpose of this Form 6-K is to report company announcements and to be incorporated by reference into Genmab A/S's existing registration statements on Form S-8.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on November 18, 2025.
Which specific registration statements does this 6-K filing get incorporated into?
This filing is incorporated into Genmab A/S's registration statements on Form S-8 with File Numbers 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What type of document is Exhibit 99.1 mentioned in the filing?
Exhibit 99.1 is described as a Company Announcement dated November 18, 2025.
Does Genmab A/S file annual reports under Form 20-F or 40-F?
The filing indicates that Genmab A/S files annual reports under Form 20-F.
Filing Stats: 214 words · 1 min read · ~1 pages · Grade level 14.4 · Accepted 2025-11-18 12:10:26
Filing Documents
- gmab_20251118x6kx1.htm (6-K) — 13KB
- gmab_20251118xex99d1.htm (EX-99.1) — 81KB
- genmab_logo.jpg (GRAPHIC) — 56KB
- 0001434265-25-000095.txt ( ) — 169KB
From the Filing
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF NOVEMBER 2025 COMMISSION FILE NUMBER 001-38976 Genmab AS (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab AS's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970, 333-277273 and 333-284876 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. EXHIBIT INDEX Exhibit Description of Exhibit 99.1 Company Announcement Dated November 18, 2025 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB AS BY s Anthony Pagano Name Anthony Pagano Title Executive Vice President Chief Financial Officer DATE November 18, 2025